Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sohn

Showing results (181-190 of 201) with videos related to

Pageof 21
Sort By:
Blood|April 1, 1986
Leukopenic chronic T cell leukemia mimicking hairy cell leukemia: association with human retrovirusesC C Sohn, D W Blayney, J L Misset, et al.
HNO|January 16, 2009
[Universal newborn hearing screening. Methodical aspects]S Hoth, K Neumann, H Weissschuh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2009
Phase I study of apoptosis gene modulation with oblimersen within preoperative chemotherapy in patients with primary breast cancerJ Rom, G von Minckwitz, F Marmé, et al.
Archives of Gynecology and Obstetrics|January 5, 2019
The impact of a cervical dysplasia diagnosis on individual cancer prevention habits over time: a bicentric case-control studyN Rippinger, J Heinzler, T Bruckner, et al.
Gynecologic Oncology|May 23, 2017
Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant, recurrent, pre-treated ovarian cancer - Results of the PACOVAR-trialC Dinkic, M Eichbaum, M Schmidt, et al.
Annals of Surgical Oncology|October 16, 2015
Can Routine Imaging After Neoadjuvant Chemotherapy in Breast Cancer Predict Pathologic Complete Response?B Schaefgen, M Mati, H P Sinn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 2008
Oblimersen combined with docetaxel, adriamycin and cyclophosphamide as neo-adjuvant systemic treatment in primary breast cancer: final results of a multicentric phase I studyJ Rom, G von Minckwitz, W Eiermann, et al.
The Journal of Investigative Dermatology|July 6, 2012
Epigallocatechin-3-gallate suppresses IGF-I-induced lipogenesis and cytokine expression in SZ95 sebocytesMyung Im, Soo Y Kim, Kyung C Sohn, et al.
Breast (Edinburgh, Scotland)|February 8, 2012
Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unitJ Heil, A Gondos, G Rauch, et al.
Heart and Vessels. Supplement|January 1, 1992
Takayasu arteritis in Korean children: clinical report of seventy casesC Y Hong, Y S Yun, J Y Choi, et al.
Pageof 21

Showing results (181-190 of 201) with videos related to

Sort By:
Pageof 21
Blood|April 1, 1986
Leukopenic chronic T cell leukemia mimicking hairy cell leukemia: association with human retrovirusesC C Sohn, D W Blayney, J L Misset, et al.
HNO|January 16, 2009
[Universal newborn hearing screening. Methodical aspects]S Hoth, K Neumann, H Weissschuh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2009
Phase I study of apoptosis gene modulation with oblimersen within preoperative chemotherapy in patients with primary breast cancerJ Rom, G von Minckwitz, F Marmé, et al.
Archives of Gynecology and Obstetrics|January 5, 2019
The impact of a cervical dysplasia diagnosis on individual cancer prevention habits over time: a bicentric case-control studyN Rippinger, J Heinzler, T Bruckner, et al.
Gynecologic Oncology|May 23, 2017
Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant, recurrent, pre-treated ovarian cancer - Results of the PACOVAR-trialC Dinkic, M Eichbaum, M Schmidt, et al.
Annals of Surgical Oncology|October 16, 2015
Can Routine Imaging After Neoadjuvant Chemotherapy in Breast Cancer Predict Pathologic Complete Response?B Schaefgen, M Mati, H P Sinn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 2008
Oblimersen combined with docetaxel, adriamycin and cyclophosphamide as neo-adjuvant systemic treatment in primary breast cancer: final results of a multicentric phase I studyJ Rom, G von Minckwitz, W Eiermann, et al.
The Journal of Investigative Dermatology|July 6, 2012
Epigallocatechin-3-gallate suppresses IGF-I-induced lipogenesis and cytokine expression in SZ95 sebocytesMyung Im, Soo Y Kim, Kyung C Sohn, et al.
Breast (Edinburgh, Scotland)|February 8, 2012
Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unitJ Heil, A Gondos, G Rauch, et al.
Heart and Vessels. Supplement|January 1, 1992
Takayasu arteritis in Korean children: clinical report of seventy casesC Y Hong, Y S Yun, J Y Choi, et al.
Pageof 21